Hung-I Yeh
Overview
Explore the profile of Hung-I Yeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
282
Citations
2670
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tu K, Chang W, Lin H, Lin P, Wu Y, Lin C, et al.
Eur J Med Res
. 2025 Mar;
30(1):176.
PMID: 40089775
Objective: Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors are a standard therapy for patients who respond poorly to or cannot tolerate statins. However, identifying responders to PCSK9 inhibitors remains unclear....
2.
Lin T, Leu H, Wu Y, Tseng W, Lin T, Yeh H, et al.
Biomark Res
. 2025 Feb;
13(1):24.
PMID: 39920870
Introduction: Neutrophil gelatinase-associated lipocalin (NGAL) modulates the enzymatic activity of matrix metalloproteinase-9, which is an important mediator of plaque instability in atherosclerosis. High NGAL levels can independently predict all-cause mortality...
3.
Lee Y, Wu Y, Su C, Wang B, Yang S, Lee H, et al.
Redox Biol
. 2024 Nov;
78:103427.
PMID: 39566163
Atherosclerosis caused major morbidity and mortality worldwide. Molecules possessing lipid-lowering and/or anti-inflammatory properties are potential druggable targets against atherosclerosis. We examined the anti-atherosclerotic effects of fluorescent gold nanoclusters (FANC), which...
4.
Chien S, Lan W, Yun C, Sung K, Yeh H, Tsai C, et al.
Sci Rep
. 2024 Oct;
14(1):25477.
PMID: 39462060
Although several studies have demonstrated the cardiovascular (CV) implication of hypoalbuminemia and arterial calcification among hemodialysis patients, little is known regarding their cardiac correlates and relevant CV outcomes in asymptomatic...
5.
Chen T, Hsiao Y, Wu Y, Lin T, Sheu W, Lee T, et al.
J Formos Med Assoc
. 2024 Oct;
PMID: 39455400
Objective: This study aimd to assess recent trends in the control of low-density lipoprotein cholesterol (LDL-C) and the utilization of lipid-lowering drugs (LLD) among patients with atherosclerotic cardiovascular disease (ASCVD)...
6.
Lu T, Chien S, Leu H, Yin W, Tseng W, Wu Y, et al.
J Chin Med Assoc
. 2024 Aug;
87(12):1054-1059.
PMID: 39175125
Background: Diabetes and insulin resistance alter the physiological state of serum albumin (SA), which is a prognostic marker for stable coronary artery disease (CAD). However, whether the SA concentration is...
7.
Tien T, Wu Y, Chang C, Hung C, Lee Y, Lee H, et al.
J Cell Mol Med
. 2024 Jul;
28(13):e18523.
PMID: 38957039
This research explores the role of microRNA in senescence of human endothelial progenitor cells (EPCs) induced by replication. Hsa-miR-134-5p was found up-regulated in senescent EPCs where overexpression improved angiogenic activity....
8.
Chung F, Chao T, Lee A, Sung K, Huang W, Hsiao C, et al.
JACC Adv
. 2024 Jun;
2(9):100654.
PMID: 38938730
Background: Left ventricular (LV) systolic strain is presumably a more sensitive myocardial indicator than LV ejection fraction (LVEF). Data regarding the use of LV strain in clinical risk stratification and...
9.
Chou Y, Lee Y, Su C, Lee H, Hsieh C, Tien T, et al.
J Cell Mol Med
. 2024 Jun;
28(12):e18489.
PMID: 38899522
This study explores the impact of senescence on autocrine C-C motif chemokine ligand 5 (CCL5) in human endothelial progenitor cell (EPCs), addressing the poorly understood decline in number and function...
10.
Lin L, Chang T, Leu H, Huang C, Wu T, Chou R, et al.
Clin Res Cardiol
. 2024 May;
PMID: 38740723
Background: Both the clinical and mechanistic impacts of endocan were not well elucidated especially in coronary artery disease (CAD). Objective: This study aimed to investigate the prognostic and potential pathological...